JPS5777676A - Carbostyril derivative - Google Patents

Carbostyril derivative

Info

Publication number
JPS5777676A
JPS5777676A JP55154071A JP15407180A JPS5777676A JP S5777676 A JPS5777676 A JP S5777676A JP 55154071 A JP55154071 A JP 55154071A JP 15407180 A JP15407180 A JP 15407180A JP S5777676 A JPS5777676 A JP S5777676A
Authority
JP
Japan
Prior art keywords
formula
compound
condensation agent
drug
carbostyril derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55154071A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0143747B2 (enExample
Inventor
Michiaki Tominaga
Nagao Yo
Hidenori Ogawa
Kazuyuki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP55154071A priority Critical patent/JPS5777676A/ja
Priority to IT8149588A priority patent/IT1210585B/it
Priority to CA000389068A priority patent/CA1209575A/en
Priority to AT0460281A priority patent/AT381701B/de
Priority to DE3142982A priority patent/DE3142982C2/de
Priority to ZA817515A priority patent/ZA817515B/xx
Priority to ES507198A priority patent/ES8306743A1/es
Priority to SU813349303A priority patent/SU1426452A3/ru
Priority to DE3153260A priority patent/DE3153260C2/de
Priority to NL8104923A priority patent/NL194205C/nl
Priority to US06/316,572 priority patent/US4415572A/en
Priority to AU76996/81A priority patent/AU524419B2/en
Priority to CH199/85A priority patent/CH656616A5/de
Priority to NO813678A priority patent/NO158099C/no
Priority to DK480381A priority patent/DK155665C/da
Priority to SE8106430A priority patent/SE448877B/sv
Priority to FR8120470A priority patent/FR2493320B1/fr
Priority to GB8132743A priority patent/GB2086896B/en
Priority to PH26427A priority patent/PH17962A/en
Priority to FI813408A priority patent/FI77450C/fi
Priority to PT73910A priority patent/PT73910B/pt
Priority to BE0/206407A priority patent/BE890942A/fr
Priority to MX7855A priority patent/MX155101A/es
Priority to CH6942/81A priority patent/CH650782A5/de
Priority to KR1019810004240A priority patent/KR860001944B1/ko
Publication of JPS5777676A publication Critical patent/JPS5777676A/ja
Priority to ES520637A priority patent/ES8403885A1/es
Priority to ES520638A priority patent/ES520638A0/es
Priority to AR83292954A priority patent/AR242563A1/es
Priority to AR84296053A priority patent/AR242375A1/es
Priority to NL8403096A priority patent/NL8403096A/nl
Priority to FR848416085A priority patent/FR2552760B1/fr
Priority to DK561984A priority patent/DK159436C/da
Priority to SE8406209A priority patent/SE466655B/sv
Priority to IT8547867A priority patent/IT1226479B/it
Priority to MX848185A priority patent/MX8481A/es
Priority to KR1019860007984A priority patent/KR860001945B1/ko
Priority to KR1019860007985A priority patent/KR860001958B1/ko
Priority to KR1019860007986A priority patent/KR860001959B1/ko
Priority to KR1019860007987A priority patent/KR860001960B1/ko
Publication of JPH0143747B2 publication Critical patent/JPH0143747B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
JP55154071A 1980-10-31 1980-10-31 Carbostyril derivative Granted JPS5777676A (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
JP55154071A JPS5777676A (en) 1980-10-31 1980-10-31 Carbostyril derivative
IT8149588A IT1210585B (it) 1980-10-31 1981-10-29 Composti carbostirilici composizioni che li contengono e procedimenti per la loro preparazione
CA000389068A CA1209575A (en) 1980-10-31 1981-10-29 Carbostyril compounds, compositions containing same and processes for preparing same
AT0460281A AT381701B (de) 1980-10-31 1981-10-29 Verfahren zur herstellung von neuen carbostyrilverbindungen und ihren pharmazeutisch annehmbaren salzen
DE3142982A DE3142982C2 (de) 1980-10-31 1981-10-29 Carbostyrilverbindungen, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
ZA817515A ZA817515B (en) 1980-10-31 1981-10-29 Carbostyril compounds,compositions containing same and processes for preparing same
ES507198A ES8306743A1 (es) 1980-10-31 1981-10-29 Procedimiento de preparar compuesto carbostiribicos.
SU813349303A SU1426452A3 (ru) 1980-10-31 1981-10-29 Способ получени производных карбостирила или их галогенводородных солей
DE3153260A DE3153260C2 (enExample) 1980-10-31 1981-10-29
FI813408A FI77450C (fi) 1980-10-31 1981-10-30 Foerfarande foer framstaellning av piperazinylsubstituerade karbostyrilderivat, vilka aer anvaendbara som kardiotoniska medel.
PH26427A PH17962A (en) 1980-10-31 1981-10-30 Carbostyril compounds,compositions containing same
AU76996/81A AU524419B2 (en) 1980-10-31 1981-10-30 Piperazine-substituted carbostyril compounds
CH199/85A CH656616A5 (de) 1980-10-31 1981-10-30 Carbonsaeureverbindungen und verfahren zu deren herstellung.
NO813678A NO158099C (no) 1980-10-31 1981-10-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
DK480381A DK155665C (da) 1980-10-31 1981-10-30 Analogifremgangsmaade til fremstilling af carbostyrilforbindelser
SE8106430A SE448877B (sv) 1980-10-31 1981-10-30 Karbostyrilforeningar, farmaceutiska kompositioner innehallande dessa och forfaranden for framstellning derav
FR8120470A FR2493320B1 (fr) 1980-10-31 1981-10-30 Nouveaux derives de carbostyrile utiles notamment comme cardiotoniques, leurs procedes de preparation et medicaments les contenant
GB8132743A GB2086896B (en) 1980-10-31 1981-10-30 Carbostyril compounds compositions containing same and process for preparing same
US06/316,572 US4415572A (en) 1980-10-31 1981-10-30 Piperazinylcarbostyril compounds
NL8104923A NL194205C (nl) 1980-10-31 1981-10-30 Carbostyrilverbindingen met cardiotonische werking en preparaten die deze verbindingen bevatten.
PT73910A PT73910B (en) 1980-10-31 1981-10-30 Process for preparing carbostyril compounds and compositions containing same
BE0/206407A BE890942A (fr) 1980-10-31 1981-10-30 Nouveaux derives de carbostyrile utiles notamment comme cardiotoniques, leurs procedes de preparation et medicaments les contenant
MX7855A MX155101A (es) 1980-10-31 1981-10-30 Procedimiento para la preparacion de derivados de carboestirilo
CH6942/81A CH650782A5 (de) 1980-10-31 1981-10-30 Carbostyrilverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
KR1019810004240A KR860001944B1 (ko) 1980-10-31 1981-10-31 카보스티릴 화합물의 제조방법
ES520638A ES520638A0 (es) 1980-10-31 1983-03-15 Procedimiento de preparar compuestos carbostirilicos.
ES520637A ES8403885A1 (es) 1980-10-31 1983-03-15 Metodo de preparar compuestos carbostirilicos.
AR83292954A AR242563A1 (es) 1980-10-31 1983-05-06 Procedimiento para preparar derivados de (piperazin-1-il)-carboestirilo o de 3,4-dihidrocarboestirilo.
AR84296053A AR242375A1 (es) 1980-10-31 1984-03-21 Procedimiento para preparar compuestos de 5-, 6-,7- u 8-piperazin-carboestirilo o 3,4-dihidrocarboestirilo.
NL8403096A NL8403096A (nl) 1980-10-31 1984-10-11 Piperazinokaneelzuur- en piperazinofenylpropionzuurderivaten en werkwijze voor de bereiding daarvan.
FR848416085A FR2552760B1 (fr) 1980-10-31 1984-10-19 Procede pour l'obtention de derives de carbostyrile et intermediaires de synthese
DK561984A DK159436C (da) 1980-10-31 1984-11-27 Substituerede piperazino-substituerede phenylcarboxylsyreforbindelser
SE8406209A SE466655B (sv) 1980-10-31 1984-12-06 Karboxylsyrafoereningar samt foerfarande foer framstaellning daerav
IT8547867A IT1226479B (it) 1980-10-31 1985-03-26 Composti di acido carbossilico utili come prodotti intermedi per la preparazione di composti carbostirilici
MX848185A MX8481A (es) 1980-10-31 1985-08-09 Procedimiento para preparar compuestos de carboestirilo.
KR1019860007984A KR860001945B1 (ko) 1980-10-31 1986-09-24 카보스티릴 화합물의 제조방법
KR1019860007985A KR860001958B1 (ko) 1980-10-31 1986-09-24 카보스티릴 화합물의 제조방법
KR1019860007986A KR860001959B1 (ko) 1980-10-31 1986-09-24 카보스티릴 화합물의 제조방법
KR1019860007987A KR860001960B1 (ko) 1980-10-31 1986-09-24 카보스티릴 화합물의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55154071A JPS5777676A (en) 1980-10-31 1980-10-31 Carbostyril derivative

Publications (2)

Publication Number Publication Date
JPS5777676A true JPS5777676A (en) 1982-05-15
JPH0143747B2 JPH0143747B2 (enExample) 1989-09-22

Family

ID=15576252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55154071A Granted JPS5777676A (en) 1980-10-31 1980-10-31 Carbostyril derivative

Country Status (24)

Country Link
US (1) US4415572A (enExample)
JP (1) JPS5777676A (enExample)
KR (1) KR860001944B1 (enExample)
AR (2) AR242563A1 (enExample)
AT (1) AT381701B (enExample)
AU (1) AU524419B2 (enExample)
BE (1) BE890942A (enExample)
CA (1) CA1209575A (enExample)
CH (2) CH650782A5 (enExample)
DE (2) DE3142982C2 (enExample)
DK (1) DK155665C (enExample)
ES (3) ES8306743A1 (enExample)
FI (1) FI77450C (enExample)
FR (2) FR2493320B1 (enExample)
GB (1) GB2086896B (enExample)
IT (2) IT1210585B (enExample)
MX (1) MX8481A (enExample)
NL (2) NL194205C (enExample)
NO (1) NO158099C (enExample)
PH (1) PH17962A (enExample)
PT (1) PT73910B (enExample)
SE (2) SE448877B (enExample)
SU (1) SU1426452A3 (enExample)
ZA (1) ZA817515B (enExample)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5883677A (ja) * 1981-11-11 1983-05-19 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS5929667A (ja) * 1982-08-13 1984-02-16 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体および強心剤
JPS61145162A (ja) * 1984-12-19 1986-07-02 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS61152666A (ja) * 1984-12-21 1986-07-11 デユフアル・インテルナチオナル・レセールフ・ベー・ヴエー 新規な二環式ヘテロアリールピペラジン誘導体、その製造方法およびその誘導体を有効成分とする向精神医薬組成物
JPS61267556A (ja) * 1984-12-18 1986-11-27 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS62138473A (ja) * 1985-12-12 1987-06-22 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体−シクロデキストリン包接化合物
US4760256A (en) * 1984-06-01 1988-07-26 Fuji Photo Film Co., Ltd. Radiation image recording and read-out apparatus
JPS63225357A (ja) * 1987-03-12 1988-09-20 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
WO1993000902A1 (fr) * 1991-07-03 1993-01-21 Otsuka Pharmaceutical Co., Ltd. Regulateur d'apoptose
WO1993011769A1 (fr) * 1991-12-10 1993-06-24 Otsuka Pharmaceutical Co., Ltd Agent anticancereux
WO1994004504A1 (fr) * 1992-08-19 1994-03-03 Otsuka Pharmaceutical Co., Ltd. Regulateur d'apoptose
JPH06192229A (ja) * 1992-12-26 1994-07-12 Kissei Pharmaceut Co Ltd ３，４−ジヒドロカルボスチリル誘導体
WO1994020107A1 (fr) * 1993-03-02 1994-09-15 Otsuka Pharmaceutical Co., Ltd. Inhibiteur de rejet pour transplantations et inhibiteur de production d'interleukine 1
JPH0733664A (ja) * 1993-07-26 1995-02-03 Otsuka Pharmaceut Co Ltd 平滑筋細胞増殖抑制剤
US8153793B2 (en) 2005-09-27 2012-04-10 Shionogi & Co., Ltd. Sulfonamide derivative having PGD2 receptor antagonistic activity

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
AU577802B2 (en) * 1983-10-17 1988-10-06 Duphar International Research B.V. Blood-pressure lowering piperazine derivatives
JPS60126270A (ja) * 1983-12-14 1985-07-05 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
US4774246A (en) * 1984-01-26 1988-09-27 Abbott Laboratories Quinoline antibacterial compounds
CA1292234C (en) * 1984-05-29 1991-11-19 Simon Fraser Campbell Heterocyclic-substituted quinolone inotropic agents
DE3582371D1 (de) * 1984-07-06 1991-05-08 Otsuka Pharma Co Ltd Oxindolverbindungen, diese enthaltende zusammensetzungen sowie verfahren zur herstellung derselben.
US4760064A (en) * 1984-12-18 1988-07-26 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds, compositions containing same and processes for preparing same
EP0189612B1 (en) * 1984-12-21 1992-11-04 Duphar International Research B.V New pharmaceutical compositions having a psychotropic activity
US4845100A (en) * 1985-04-12 1989-07-04 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same
DE3524067A1 (de) * 1985-07-05 1987-01-08 Boehringer Mannheim Gmbh Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
US4689325A (en) * 1985-12-23 1987-08-25 Abbott Laboratories Isoxazolo-pyrido-phenoxazine and isothiazolo-pyrido-phenoxazine derivatives
US4687770A (en) * 1985-12-23 1987-08-18 Abbott Laboratories Isoxazolo-pyrido-benzoxazine and isothiazolo-pyrido-benzoxazine derivatives
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
GB8630702D0 (en) * 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
GB8827189D0 (en) * 1988-11-21 1988-12-29 Fujisawa Pharmaceutical Co 2(1h)-quinolinone compounds processes for preparation thereof & pharmaceutical composition comprising same
US5543412A (en) * 1991-07-03 1996-08-06 Otsuka Pharmaceutical Co., Ltd. Hepatitis treatment with carbostyril compounds
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
GB9326232D0 (en) * 1993-12-23 1994-02-23 Zeneca Ltd Chemical compounds
GB9326373D0 (en) * 1993-12-23 1994-02-23 Zeneca Ltd Chemical compounds
US5504093A (en) * 1994-08-01 1996-04-02 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication
HU227454B1 (en) * 1996-03-29 2011-06-28 Duphar Int Res Piperazine and piperidine compounds, process for their preparation and pharmaceutical compositions containing the same
GB2312843A (en) * 1996-05-07 1997-11-12 Merck & Co Inc Method of treating rheumatoid arthritis
US5684007A (en) * 1996-09-05 1997-11-04 Otsuka Pharmaceutical Co., Ltd. Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
WO2001016133A2 (en) 1999-08-27 2001-03-08 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
IL148045A0 (en) * 1999-08-27 2002-09-12 Ligand Pharm Inc Androgen receptor modulator compounds and methods
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
WO2001019770A2 (en) 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7816372B2 (en) * 2003-08-22 2010-10-19 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
JP2008533090A (ja) * 2005-03-14 2008-08-21 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 心血管疾患の防止方法
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治疗胃肠道病症的组成物
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1278385B (de) * 1965-03-30 1968-09-26 Bayer Ag Aufhellungsmittel
GB1299172A (en) * 1968-10-15 1972-12-06 Lilly Industries Ltd Heterocyclic anti-inflammatory agents
GB1574665A (en) * 1976-05-08 1980-09-10 Otsuka Pharma Co Ltd 3,4-dihydrocarbostyril derivatives and process for preparing the same
JPS54130589A (en) * 1978-03-31 1979-10-09 Yoshitomi Pharmaceut Ind Ltd Pyridazine derivative and its preparation
JPS54135785A (en) * 1978-04-12 1979-10-22 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative and its preparation
JPS54138585A (en) * 1978-04-18 1979-10-27 Yoshitomi Pharmaceut Ind Ltd Pyridazine derivative and its preparation
JPS54141785A (en) * 1978-04-26 1979-11-05 Yoshitomi Pharmaceut Ind Ltd Preparation of carboxylic acid derivative
JPS6017072B2 (ja) * 1978-09-05 1985-04-30 三菱電機株式会社 赤熱金属検出器
JPS5549319A (en) * 1978-10-06 1980-04-09 Yoshitomi Pharmaceut Ind Ltd Remedy for suppression of blood platelet-agglutination
JPS5553283A (en) * 1978-10-12 1980-04-18 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative
JPS5576872A (en) * 1978-12-06 1980-06-10 Yoshitomi Pharmaceut Ind Ltd Imidazolidinone derivative
JPS5583781A (en) * 1978-12-19 1980-06-24 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5883677A (ja) * 1981-11-11 1983-05-19 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS5929667A (ja) * 1982-08-13 1984-02-16 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体および強心剤
US4760256A (en) * 1984-06-01 1988-07-26 Fuji Photo Film Co., Ltd. Radiation image recording and read-out apparatus
JPS61267556A (ja) * 1984-12-18 1986-11-27 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS61145162A (ja) * 1984-12-19 1986-07-02 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS61152666A (ja) * 1984-12-21 1986-07-11 デユフアル・インテルナチオナル・レセールフ・ベー・ヴエー 新規な二環式ヘテロアリールピペラジン誘導体、その製造方法およびその誘導体を有効成分とする向精神医薬組成物
JPS62138473A (ja) * 1985-12-12 1987-06-22 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体−シクロデキストリン包接化合物
JPS63225357A (ja) * 1987-03-12 1988-09-20 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
WO1993000902A1 (fr) * 1991-07-03 1993-01-21 Otsuka Pharmaceutical Co., Ltd. Regulateur d'apoptose
WO1993011769A1 (fr) * 1991-12-10 1993-06-24 Otsuka Pharmaceutical Co., Ltd Agent anticancereux
WO1994004504A1 (fr) * 1992-08-19 1994-03-03 Otsuka Pharmaceutical Co., Ltd. Regulateur d'apoptose
JPH06192229A (ja) * 1992-12-26 1994-07-12 Kissei Pharmaceut Co Ltd ３，４−ジヒドロカルボスチリル誘導体
WO1994020107A1 (fr) * 1993-03-02 1994-09-15 Otsuka Pharmaceutical Co., Ltd. Inhibiteur de rejet pour transplantations et inhibiteur de production d'interleukine 1
US5521185A (en) * 1993-03-02 1996-05-28 Otsuka Pharmaceutical Co., Ltd. Methods for inhibiting graft rejection and IL-1 production
JPH0733664A (ja) * 1993-07-26 1995-02-03 Otsuka Pharmaceut Co Ltd 平滑筋細胞増殖抑制剤
US8153793B2 (en) 2005-09-27 2012-04-10 Shionogi & Co., Ltd. Sulfonamide derivative having PGD2 receptor antagonistic activity
JP5114202B2 (ja) * 2005-09-27 2013-01-09 塩野義製薬株式会社 Ｐｇｄ２受容体アンタゴニスト活性を有するスルホンアミド誘導体
US8993763B2 (en) 2005-09-27 2015-03-31 Shionogi & Co., Ltd. Sulfonamide derivative having PGD2 receptor antagonistic activity
US9440938B2 (en) 2005-09-27 2016-09-13 Shionogi & Co., Ltd. Sulfonamide derivative having PGD2 receptor antagonistic activity

Also Published As

Publication number Publication date
MX8481A (es) 1994-02-28
FI77450B (fi) 1988-11-30
AR242563A1 (es) 1993-04-30
ES8403886A1 (es) 1984-04-16
IT8547867A0 (it) 1985-03-26
FI77450C (fi) 1989-03-10
DK480381A (da) 1982-05-01
DE3153260A1 (enExample) 1985-05-15
ZA817515B (en) 1982-10-27
PH17962A (en) 1985-02-20
AU524419B2 (en) 1982-09-16
BE890942A (fr) 1982-02-15
AT381701B (de) 1986-11-25
IT1226479B (it) 1991-01-16
ES507198A0 (es) 1983-06-16
DE3153260C2 (enExample) 1989-05-24
FR2552760B1 (fr) 1988-08-05
NO158099C (no) 1988-07-13
DE3142982C2 (de) 1985-12-19
PT73910B (en) 1983-04-18
GB2086896A (en) 1982-05-19
ES520637A0 (es) 1984-04-16
CH650782A5 (de) 1985-08-15
US4415572A (en) 1983-11-15
IT8149588A0 (it) 1981-10-29
DK155665B (da) 1989-05-01
FR2552760A1 (fr) 1985-04-05
NO813678L (no) 1982-05-03
SU1426452A3 (ru) 1988-09-23
SE8106430L (sv) 1982-05-01
KR860001944B1 (ko) 1986-11-01
SE8406209D0 (sv) 1984-12-06
FR2493320B1 (fr) 1985-08-23
AR242375A1 (es) 1993-03-31
SE448877B (sv) 1987-03-23
PT73910A (en) 1981-11-01
KR830007607A (ko) 1983-11-04
DE3142982A1 (de) 1982-06-24
FR2493320A1 (fr) 1982-05-07
FI813408L (fi) 1982-05-01
AU7699681A (en) 1982-05-06
NL194205B (nl) 2001-05-01
NO158099B (no) 1988-04-05
ATA460281A (de) 1986-04-15
JPH0143747B2 (enExample) 1989-09-22
SE8406209L (sv) 1984-12-06
NL194205C (nl) 2001-09-04
IT1210585B (it) 1989-09-14
ES8403885A1 (es) 1984-04-16
SE466655B (sv) 1992-03-16
CA1209575A (en) 1986-08-12
NL8403096A (nl) 1985-02-01
CH656616A5 (de) 1986-07-15
NL8104923A (nl) 1982-05-17
DK155665C (da) 1989-09-04
ES520638A0 (es) 1984-04-16
GB2086896B (en) 1984-10-10
ES8306743A1 (es) 1983-06-16

Similar Documents

Publication Publication Date Title
JPS5777676A (en) Carbostyril derivative
IE791565L (en) Crop cutting apparatus
JPS5649378A (en) Tetrazolylalkoxycarbostyril derivative
JPS5690031A (en) Preparation of aromatic aldehyde
JPS5649361A (en) Carbostyril derivative
JPS56103168A (en) Thiazole derivative, its preparation, and antihistaminic agent containing the same
JPS5780322A (en) Cardiotonic agent
JPS55127371A (en) Carbostyril derivative
JPS57142972A (en) Carbostyril derivative
JPS5750935A (en) 1,4-benzoquinone derivative
JPS5649364A (en) Carbostyril derivative
JPS56103185A (en) Malonamidoxa-dethia-cephem compound
JPS5780321A (en) Cardiotonic agent
JPS5649359A (en) Carbostyril derivative
JPS5772981A (en) 1,8-naphthyridine derivative and its salt
JPS5754177A (ja) Chikanchiazoorujudotai
EP0311051A3 (en) Pyridylacetonitrile derivatives
JPS55129268A (en) Carbostyril derivative
JPS5515457A (en) Dithiocarbamic acid derivative
JPS54100384A (en) Novel penicillamine derivative
JPS57106679A (en) Novel piperidne derivative, its preparation, and pharmaceutical composition containing the same
JPS5782390A (en) Carbostyril derivative
JPS5735588A (en) Carbostyrile derivative
EP0127150A3 (en) 2,6-disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same
JPS57154183A (en) Omega-piperazinylalkanoylalkylene dioxybenzenes and their acid addition salts